- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Solid Biosciences Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Solid Biosciences Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Solid Biosciences Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) TranscriptMar 28, 2023
- Solid Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Solid Biosciences Inc To Acquire Aavantibio Inc Call TranscriptSep 30, 2022
- Q1 2022 Solid Biosciences Inc Earnings Call TranscriptApr 27, 2022$9.65 (-16.98%)Earnings
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Solid Biosciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Q1 2021 Solid Biosciences Inc Earnings Call TranscriptMay 14, 2021$52.35 (-21.40%)Earnings
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Solid Biosciences Inc. - Special Call TranscriptMar 15, 2021
- Solid Biosciences Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Solid Biosciences Inc Earnings Call TranscriptNov 05, 2020$48.6Earnings
- Solid Biosciences Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Solid Biosciences Inc. - Special Call TranscriptDec 18, 2019
- Solid Biosciences Inc. - Special Call TranscriptNov 12, 2019
Solid Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good afternoon. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. So welcome to our Global Healthcare Conference. It is my great pleasure to introduce our next presenting company, Solid Biosciences. With me, we have Bo Cumbo, President and Chief Executive Officer. And Bo, maybe you start with a little bit overview of the company, and we can dive into the questions.
Great. Thank you. First of all, thank you, Gena, for the invitation to the conference, and thank you, Barclays. I'm Bo Cumbo, CEO of Solid Biosciences. Solid is a precision genetic medicine company, focused mainly on neuromuscular and cardiomyopathies. Solid purchased a company called AavantiBio, closed on this on December 2, 2022. I came from AavantiBio as the CEO of AavantiBio myself and my management team moved over into Solid Biosciences.
We focus on Duchenne muscular dystrophy, as our lead drug, followed by Friedreich's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)